2023-07-06 07:00:28
Posted Jul 6, 2023, 9:00 a.m. Updated Jul 6, 2023, 9:04 a.m.
Vicat: HSBC goes from “lighten” to “keep” and raises its target from 22 to 27 euros.
Argan : Berenberg begins his follow-up to “hold” with a target price of 82 euros.
Engie : the same intermediary, on purchase, slightly upwards its target from 17 to 17.5 euros.
Sanofi : to “keep”, Berenberg, still, raises its target from 105 to 107 euros.
BNP Paribas : JPMorgan, at “neutral”, reduced its target from 69 to 68 euros.
Legrand : JPMorgan, at “neutral”, is now targeting 96 euros, once morest 93 euros previously.
Societe Generale : the same intermediary, also at “neutral”, lowers its target from 31 to 30 euros.
Nexans : at “neutral”, JPMorgan raises its target price from 89 to 93 euros.
Amundi: JPMorgan, always, to “overweight”, adjusts its target price downwards from 73.4 to 71.2 euros. Credit Suisse, to “neutral”, reduces its target from 64 to 63 euros.
Euronext : Credit Suisse, at “outperformance”, lowers its target from 88 to 84 euros.
Teleperformance: HSBC, for purchase, is now targeting 250 euros, once morest 280 previously.
Saint-Gobain : HSBC, also buying, lowered its price target from 85 to 75 euros.
Publicis : the same intermediary, still buying, adjusts its target downwards to 85 euros, once morest 92 euros before.
ADP : at “line weighting”, Morgan Stanley reduces its target from 147 to 145 euros.
Biomérieux : the same intermediary, to “overweight”, raises its target from 112 to 113 euros.
LVMH : Goldman Sachs, when buying, raises its target price from 920 to 970 euros.
Bouygues: Citi, at “neutral”, slightly lowers its target to 30.8 euros, once morest 31.3 euros previously.
1688629142
#Vicat #Argan #Engie #Sanofi #BNP #Paribas #Legrand #Société #Générale #Nexans #Amundi #Euronext #Teleperformance #SaintGobain #Publicis #ADP #Biomérieux #LVMH #Bouygues #find #analysts #recommendations #Thursday
